Laboratorio Farmaceutico Erfo S.p.A.

ERFO

IT0005497885

Pharmaceuticals

Market Closed - Borsa Italiana Other stock markets 11:44:59 2024-04-26 am EDT			5-day change	1st Jan Change
1.14 ^EUR	+2.24%		+3.64%	-12.98%

Mar. 29	Laboratorio Farmaceutico Erfo, revenues grow and profit remains stable	AN
Feb. 19	Mib in the red at 31,600; TIM still on top	AN

Laboratorio Farmaceutico Erfo S.p.A. completed the acquisition of 65% stake in Bodysano France on December 29, 2022.

January 15, 2023

Laboratorio Farmaceutico Erfo S.p.A. (BIT:ERFO) signed an agreement to acquire 65% stake in Bodysano France for €0.85 million on December 29, 2022. The transaction was financed by Erfo's own means.

Laboratorio Farmaceutico Erfo S.p.A. (BIT:ERFO) completed the acquisition of 65% stake in Bodysano France on January 16, 2023.

Latest news about Laboratorio Farmaceutico Erfo S.p.A.

Laboratorio Farmaceutico Erfo, revenues grow and profit remains stable	Mar. 29	AN
Mib in the red at 31,600; TIM still on top	Feb. 19	AN
European indexes down; TIM tops Mib	Feb. 19	AN
Laboratorio Farmaceutico Erfo increases revenues by 23% in 2023	Feb. 16	AN
ITALY GROWTH WINNERS & LOSERS: Erfo bullish; TrenDevice bad.	Feb. 16	AN
Mib chasing 32,000 points; Tenaris still up	Feb. 16	AN
Milan still bullish; Eni profit falls	Feb. 16	AN
Stock markets in green despite Japan and UK recession	Feb. 15	AN
Laboratorio Farmaceutico Erfo has bought back 18,000 of its own shares	Dec. 27	AN
Laboratorio Farmaceutico Erfo purchases 22,000 shares of its own stock	Dec. 15	AN
Laboratorio Farmaceutico Erfo has purchased 15,000 of its own shares	Nov. 13	AN
Futures down after Powell speech.	Nov. 10	AN
Europeans up; De' Longhi bullish after accounts	Nov. 09	AN
Laboratorio Farmaceutico Erfo, revenues up more than 20 percent in nine months	Nov. 09	AN
Laboratorio Farmaceutico Erfo purchases 18,000 shares of its own stock	23-10-06	AN
Laboratorio Farmaceutico Erfo, profit in line with 2022 in the six-month period	23-09-26	AN
Laboratorio Farmaceutico Erfo S.p.A. Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-25	CI
Laboratorio Farmaceutico Erfo buys 29,000 of its own shares	23-09-22	AN
Laboratorio Farmaceutico Erfo purchases 35,000 shares of its own stock	23-09-15	AN
Laboratorio Farmaceutico Erfo purchases 35,000 shares of its own stock	23-09-08	AN
Laboratorio Farmaceutico Erfo takes over shares for nearly EUR30,000	23-09-01	AN
Laboratorio Farmaceutico Erfo has purchased 20,000 of its own shares	23-08-25	AN
Laboratorio Farmceutico Erfo has purchased 14,000 of its own shares	23-08-21	AN
Mib up after Italy inflation; TIM on top	23-08-10	AN
Europeans up ahead of U.S. inflation data	23-08-10	AN

Chart Laboratorio Farmaceutico Erfo S.p.A.

Duration

Period

Chart Laboratorio Farmaceutico Erfo S.p.A.

More charts

Company Profile

Laboratorio Farmaceutico Erfo SpA is an Italy-based pharmaceutical company primarily engaged in the nutraceutical sector. The Company specializes in the production of nutritional supplements, that thanks to research and development carried out internally and in collaboration with the University Campus Bio-Medico of Rome and the University of Messina provides products with a scientific value in different therapeutic areas. The Company operates globally.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Ratings for Laboratorio Farmaceutico Erfo S.p.A.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1.14 EUR

Average target price

1.47 EUR

Spread / Average Target

+28.95%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
LABORATORIO FARMACEUTICO ERFO S.P.A.	-12.98%	10.95M
ELI LILLY AND COMPANY	+25.83%	661B
NOVO NORDISK A/S	+27.00%	566B
JOHNSON & JOHNSON	-6.76%	352B
MERCK & CO., INC.	+20.34%	332B
ABBVIE INC.	+3.00%	283B
ASTRAZENECA PLC	+13.09%	231B
NOVARTIS AG	+5.46%	200B
ROCHE HOLDING AG	-9.61%	195B
AMGEN INC.	-6.26%	145B

Other Pharmaceuticals